Drug Shortage Report for ACTONEL
| Report ID | 5831 |
| Drug Identification Number | 02242518 |
| Brand name | ACTONEL |
| Common or Proper name | ACTONEL 5MG |
| Company Name | ALLERGAN PHARMA CO. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RISEDRONATE SODIUM |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 28 COUNT |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2018-08-01 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2018-12-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-08-02 | English | Compare |
| v3 | 2017-10-04 | English | Compare |
| v2 | 2017-04-06 | French | Compare |
| v1 | 2017-04-06 | English | Compare |
Showing 1 to 4 of 4